2026 Flu Vaccines: Rollout & Program Advice for GPs

March 2, 2026 Nkechi Okonkwo- Health Editor Health

Australia is preparing for the 2026 influenza season with a rollout of updated flu vaccines, as announced by the Royal Australian College of General Practitioners (RACGP). This comes as healthcare professionals prepare for the annual seasonal challenge, and with novel influenza products expected to be available in 2026. The preparation follows reports indicating a decline in overall immunisation coverage across Australia, making proactive vaccination efforts even more critical.

Understanding the 2026 Flu Vaccines

The RACGP’s announcement signals a proactive approach to managing influenza, a respiratory illness that can range from mild to severe. Flu vaccines work by exposing the body to an inactive or weakened version of the influenza virus, prompting the immune system to develop antibodies that provide protection against future infection. The composition of the vaccine is updated annually to match the strains of the virus predicted to be most prevalent in the upcoming season.

Even as the specifics of the 2026 vaccine composition haven’t been released, the RACGP’s early announcement allows for planning and preparation among general practitioners and other healthcare providers. This includes ensuring adequate vaccine supply, staff training, and effective communication strategies to encourage vaccination within the community.

Who Should Consider Vaccination?

Influenza can affect people of all ages, but certain groups are at higher risk of developing severe complications. These include:

  • Individuals aged 65 years and older
  • Pregnant women
  • Young children (under 5 years traditional)
  • People with chronic medical conditions (such as asthma, diabetes, heart disease, or kidney disease)
  • Aboriginal and Torres Strait Islander people

The Australian Department of Health and Aged Care recommends annual influenza vaccination for these high-risk groups, as well as for healthcare workers to protect themselves and their patients. Vaccination is a key component of a comprehensive public health strategy to reduce the burden of influenza and prevent serious illness and hospitalisations.

Medicare Benefits and Vaccination Costs

Medicare provides some coverage for influenza vaccinations, but it’s important to understand the details of the Medicare Benefits Schedule (MBS). According to Services Australia, MBS items cover the medical service of administering the vaccine, but do not cover the cost of the vaccine itself. More information about Medicare benefits and vaccinations can be found on the MBS Online website. From July 1, 2025, a specific MBS attendance item must be billed for providing a COVID-19 vaccine support service, indicating a continued evolution in how vaccination services are financially supported.

The cost of the flu vaccine itself can vary depending on where you receive it. Some state and territory governments offer free or subsidized vaccinations for eligible individuals. It’s always best to check with your local doctor or pharmacy for pricing information.

The Importance of Ongoing Immunisation Coverage

Recent reports have highlighted a concerning trend of declining immunisation coverage in Australia. This decline increases the risk of outbreaks of vaccine-preventable diseases, including influenza. Maintaining high vaccination rates is crucial for achieving herd immunity, which protects those who are unable to be vaccinated, such as infants or individuals with certain medical conditions.

The RACGP report emphasizes the demand for GPs to actively promote immunisation and address any hesitancy among patients. This includes providing clear and accurate information about the benefits and risks of vaccination, and addressing any concerns or misconceptions.

New Influenza Products in 2026

The anticipation of new influenza products in 2026 is a positive development. These new products may offer improved protection against circulating strains of the virus, or may be more effective in certain populations. Details about these new products are expected to be released closer to the vaccination season. The RACGP’s immunisation resources will likely be updated with information on these new developments as they become available.

Counterfeit Vaccine Concerns

While Australia is well-regulated, it’s important to be aware of global issues related to vaccine safety. Reports have surfaced regarding counterfeit rabies vaccines (Abhayrab®) circulating in India since 2023. This serves as a reminder of the importance of sourcing vaccines from reputable providers and verifying their authenticity. Although this issue pertains to rabies vaccines and a different region, it underscores the need for vigilance in maintaining the integrity of the vaccine supply chain globally.

What to Expect in the Coming Months

As the 2026 flu season approaches, healthcare professionals will continue to monitor influenza activity and update their recommendations accordingly. The Medical Costs Finder, an online tool available through MBS Online, allows patients to research the costs of specialist medical services, including vaccinations. The AskMBS Email Advice Service for Providers is also available to assist health professionals with any questions regarding MBS billing requirements.

The Australian public can stay informed about influenza and vaccination by checking official public health updates from the Department of Health and Aged Care and their state and territory health departments. Talking to a qualified clinician is the best way to determine if influenza vaccination is right for you and to address any individual health concerns.